POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
批准号:
3173602
负责人:
EDWARD BRESNICK
金额:
$12.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-05-01 至 1991-07-31
关键词:
DNA RNA alkylation benzopyrenes biotransformation carbopolycyclic compound chemical carcinogen chemical carcinogenesis chemical hydration chromatography drug metabolism epoxides glutathione glutathione analog laboratory mouse laboratory rat methylcholanthrene microsomes phenobarbital tissue /cell culture
中文摘要
我们的长期目标是了解耐药性的分子基础
英文摘要
Our long-term objective is to understand the molecular basis for resistance
and susceptibility to polycyclic hydrocarbon-induced carcinogenesis. We
have previously postulated that benzo(a)pyrene (BaP) and
3-methylcholanthrene (3MC) induce cytochrome P450c in the rat after
complexing with high affinity and in saturable manner to a 4S cytosolic
protein. The latter would translocate into the nucleus, interact with a
specific region of the cytochrome P450c gene, and increase transcription of
this gene. We have now purified the 4S binding protein and have formulated
the following specific aims for our investigations. We will a) produce
monoclonal antibody to this purified protein, will characterize the
"receptor", localize this binding protein intracellularly, b) isolate the
gene for this 4S binding protein by screening a lambda gtll expression
library with either the antibody to this protein or with an oligonucleotide
probe, c) characterize the gene as to DNA sequence and cis-regulatory
elements, d) demonstrate that the 4S binding protein acts as a
transcriptional factor through the use of truncated cytochrome P450c gene
and in vitro transcriptional assay systems, e) isolate the 9S TCDD-binding
protein, prepare monoclonal antibody to it and differentiate this binding
protein from the 4S component, f) define the specific regions of
interaction of both the 4S and 9S binding proteins with the cytochrome
P450c gene, and g) convert a "receptor-negative" cell, such as early
passage RL-PR-C rat hepatocytes, to a "receptor-positive" one by
transfection and demonstrate the subsequent effects of this transfection on
the induction of cytochrome P450c. We hope that through these specific
aims we will have a better understanding of the role of the binding
proteins in the induction of cytochrome P450c.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6447946
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2001
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6573837
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2001
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6357009
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2000
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6217338
-
项目类别:
-
资助金额:$13.79万
-
财政年份:1999
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6300179
-
项目类别:
-
资助金额:$13.79万
-
财政年份:1999
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6269068
-
项目类别:
-
资助金额:$7.64万
-
财政年份:1997
-
负责人:EDWARD BRESNICK
-
依托单位:
GLYCINE N METHYL TRANSFERASE, A REGULATOR OF CYP1A1
-
批准号:2733366
-
项目类别:
-
资助金额:$25.35万
-
财政年份:1997
-
负责人:EDWARD BRESNICK
-
依托单位:
GLYCINE N METHYL TRANSFERASE, A REGULATOR OF CYP1A1
-
批准号:2377219
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1997
-
负责人:EDWARD BRESNICK
-
依托单位:
MAJOR PROGRAMS FOR CANCER CENTER SUPPORT
-
批准号:6236521
-
项目类别:
-
资助金额:$14.68万
-
财政年份:1997
-
负责人:EDWARD BRESNICK
-
依托单位:
PROTEIN SEQUENCER SYSTEM
-
批准号:3521395
-
项目类别:
-
资助金额:$11.0万
-
财政年份:1992
-
负责人:EDWARD BRESNICK
-
依托单位:
CANCER BIOLOGY AND CARCINOGENESIS
-
批准号:3533837
-
项目类别:
-
资助金额:$14.36万
-
财政年份:1991
-
负责人:EDWARD BRESNICK
-
依托单位:
CANCER BIOLOGY AND CARCINOGENESIS
-
批准号:3533838
-
项目类别:
-
资助金额:$14.25万
-
财政年份:1991
-
负责人:EDWARD BRESNICK
-
依托单位:
CANCER BIOLOGY AND CARCINOGENESIS
-
批准号:2085774
-
项目类别:
-
资助金额:$13.89万
-
财政年份:1991
-
负责人:EDWARD BRESNICK
-
依托单位:
APPLIED BIOSYSTEMS PROTEIN SEQUENCER & PTH ANALYZER
-
批准号:3520222
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1989
-
负责人:EDWARD BRESNICK
-
依托单位:
CHEMOPREVENTION OF MAM ACETATE INDUCED COLON CANCER
-
批准号:3620557
-
项目类别:
-
资助金额:$36.88万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
-
批准号:3173604
-
项目类别:
-
资助金额:$17.17万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
-
批准号:2089032
-
项目类别:
-
资助金额:$19.55万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
-
批准号:3173603
-
项目类别:
-
资助金额:$16.11万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523237
-
项目类别:
-
资助金额:$1.62万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
POLYCYCLIC HYDROCARBON METABOLISM AND CARCINOGENESIS
-
批准号:2089030
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1988
-
负责人:EDWARD BRESNICK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: